The Food and Drug Administration has rehired controversial Dr. Vinay Prasad as the head of the center that regulates vaccines and biotech therapies after he was fired pursuant to an order from the White House.
Leading up to his firing, Prasad made many controversial decisions, and the White House was fed up with his obstruction of medicines and therapies used by patients with life-threatening conditions. As a result, many felt that Prasad undermined President Donald J. Trump’s landmark “Right to Try” legislation. Now that he has returned to the job, it makes sense for Prasad to use his great knowledge of biologics to expedite lifesaving medicines and therapies in an effort to repair his image.
President Donald Trump’s Right to Try Act, signed into law in
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!